Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
- As of  04/18/25, 03:15:58 PM:   21 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for NULL

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-11-10 16:20:57.0 Summit Therapeutics Inc n/a Zanganeh Maky 6.58% view
B 2020-11-10 16:11:42.0 Summit Therapeutics Inc n/a DUGGAN ROBERT W 69.94% view
B 2020-10-06 19:28:48.0 Summit Therapeutics Inc n/a DUGGAN ROBERT W 69.11% view
B 2020-09-28 16:40:31.0 Summit Therapeutics Inc n/a Zanganeh Maky 7.8% view
S 2020-09-28 16:37:32.0 Summit Therapeutics Inc n/a DUGGAN ROBERT W 64.89% view
B 2020-06-17 14:38:17.0 Summit Therapeutics plc n/a LANSDOWNE PARTNERS 100.0% view
S 2020-05-15 10:18:30.0 Summit Therapeutics plc n/a LANSDOWNE PARTNERS 5.26% view
S 2020-03-26 14:59:44.0 Summit Therapeutics plc n/a LANSDOWNE PARTNERS 6.3% view
B 2020-01-23 14:33:25.0 Summit Therapeutics plc n/a Zanganeh Maky 7.14% view
S 2020-01-16 16:30:40.0 Summit Therapeutics plc n/a DUGGAN ROBERT W 64.94% view
B 2019-12-27 16:32:04.0 Summit Therapeutics plc n/a DUGGAN ROBERT W 74.66% view
B 2019-12-10 16:04:24.0 Summit Therapeutics plc n/a DUGGAN ROBERT W 48.81% view
S 2019-02-14 15:08:07.0 Summit Therapeutics plc n/a Point72 Asset Management 2.7% view
B 2019-01-22 16:32:17.0 Summit Therapeutics plc n/a DUGGAN ROBERT W 48.81% view
S 2018-02-14 15:01:38.0 Summit Therapeutics plc n/a Point72 Asset Management 5.3% view
S 2018-01-30 12:39:57.0 Summit Therapeutics plc n/a LANSDOWNE PARTNERS 25.91% view
B 2017-09-20 13:05:52.0 Summit Therapeutics plc n/a LANSDOWNE PARTNERS 27.11% view
B 2016-02-16 13:18:44.0 Summit Therapeutics plc n/a Point72 Asset Management 8.4% view
B 2015-03-26 13:25:51.0 Summit Therapeutics plc n/a LANSDOWNE PARTNERS 25.8% view
B 2015-03-16 15:36:49.0 Summit Therapeutics plc n/a LANSDOWNE PARTNERS 16.76% view
B 2015-03-11 16:59:08.0 Summit Therapeutics plc n/a Point72 Asset Management 6.6% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.